Health Condition 1: P299- Cardiovascular disorder originating in the perinatal period, unspecified Health Condition 2: P299- Cardiovascular disorder originating in the perinatal period, unspecified Health Condition 3: P299- Cardiovascular disorder originating in the perinatal period, unspecified
Conditions
Interventions
Intervention1: Noradrenaline: This group will receive noradrenaline Intravenous infusion in a dose of 0.1-0.3 mcg/kg/min
intravenous route
Inotrope will be escalated every 30 mins till response.
C
Sponsors
Government Medical CollegeAurangabad
Eligibility
Inclusion criteria
Inclusion criteria: Neonates less than 37 weeks with suspected late onset sepsis.
Exclusion criteria
Exclusion criteria: 1.Congenital structural heart disease 2.Neonate who is already on inotropes before eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery from shock and duration of inotrope requirement . time duaration for normalisation of clinical parameters and echocardiographic parameters. Timepoint: one year | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality in both groupsTimepoint: one year | — |
Countries
India
Contacts
Public ContactVarsha Kanhu Deodhe
Government medical college, Aurangabad.
Outcome results
None listed